412 related articles for article (PubMed ID: 20832869)
1. The role of non-HLA single nucleotide polymorphisms in multiple sclerosis susceptibility.
Bahreini SA; Jabalameli MR; Saadatnia M; Zahednasab H
J Neuroimmunol; 2010 Dec; 229(1-2):5-15. PubMed ID: 20832869
[TBL] [Abstract][Full Text] [Related]
2. The genetics of multiple sclerosis: SNPs to pathways to pathogenesis.
Oksenberg JR; Baranzini SE; Sawcer S; Hauser SL
Nat Rev Genet; 2008 Jul; 9(7):516-26. PubMed ID: 18542080
[TBL] [Abstract][Full Text] [Related]
3. Association to the Glypican-5 gene in multiple sclerosis.
Lorentzen AR; Melum E; Ellinghaus E; Smestad C; Mero IL; Aarseth JH; Myhr KM; Celius EG; Lie BA; Karlsen TH; Franke A; Harbo HF
J Neuroimmunol; 2010 Sep; 226(1-2):194-7. PubMed ID: 20692050
[TBL] [Abstract][Full Text] [Related]
4. Replication of KIAA0350, IL2RA, RPL5 and CD58 as multiple sclerosis susceptibility genes in Australians.
Rubio JP; Stankovich J; Field J; Tubridy N; Marriott M; Chapman C; Bahlo M; Perera D; Johnson LJ; Tait BD; Varney MD; Speed TP; Taylor BV; Foote SJ; Butzkueven H; Kilpatrick TJ
Genes Immun; 2008 Oct; 9(7):624-30. PubMed ID: 18650830
[TBL] [Abstract][Full Text] [Related]
5. IL2RA and IL7RA genes confer susceptibility for multiple sclerosis in two independent European populations.
Weber F; Fontaine B; Cournu-Rebeix I; Kroner A; Knop M; Lutz S; Müller-Sarnowski F; Uhr M; Bettecken T; Kohli M; Ripke S; Ising M; Rieckmann P; Brassat D; Semana G; Babron MC; Mrejen S; Gout C; Lyon-Caen O; Yaouanq J; Edan G; Clanet M; Holsboer F; Clerget-Darpoux F; Müller-Myhsok B
Genes Immun; 2008 Apr; 9(3):259-63. PubMed ID: 18354419
[TBL] [Abstract][Full Text] [Related]
6. Replication of CD58 and CLEC16A as genome-wide significant risk genes for multiple sclerosis.
Hoppenbrouwers IA; Aulchenko YS; Janssens AC; Ramagopalan SV; Broer L; Kayser M; Ebers GC; Oostra BA; van Duijn CM; Hintzen RQ
J Hum Genet; 2009 Nov; 54(11):676-80. PubMed ID: 19834503
[TBL] [Abstract][Full Text] [Related]
7. SNP mapping and candidate gene sequencing in the class I region of the HLA complex: searching for multiple sclerosis susceptibility genes in Tasmanians.
Burfoot RK; Jensen CJ; Field J; Stankovich J; Varney MD; Johnson LJ; Butzkueven H; Booth D; Bahlo M; Tait BD; Taylor BV; Speed TP; Heard R; Stewart GJ; Foote SJ; Kilpatrick TJ; Rubio JP
Tissue Antigens; 2008 Jan; 71(1):42-50. PubMed ID: 17971048
[TBL] [Abstract][Full Text] [Related]
8. Evidence for VAV2 and ZNF433 as susceptibility genes for multiple sclerosis.
Nischwitz S; Cepok S; Kroner A; Wolf C; Knop M; Müller-Sarnowski F; Pfister H; Roeske D; Rieckmann P; Hemmer B; Ising M; Uhr M; Bettecken T; Holsboer F; Müller-Myhsok B; Weber F
J Neuroimmunol; 2010 Oct; 227(1-2):162-6. PubMed ID: 20598377
[TBL] [Abstract][Full Text] [Related]
9. Examination of seven candidate regions for multiple sclerosis: strong evidence of linkage to chromosome 1q44.
Kenealy SJ; Herrel LA; Bradford Y; Schnetz-Boutaud N; Oksenberg JR; Hauser SL; Barcellos LF; Schmidt S; Gregory SG; Pericak-Vance MA; Haines JL
Genes Immun; 2006 Jan; 7(1):73-6. PubMed ID: 16341055
[TBL] [Abstract][Full Text] [Related]
10. [Multiple sclerosis as a polygenic disease: an update].
Favorova OO; Kulakova OG; Boĭko AN
Genetika; 2010 Mar; 46(3):302-13. PubMed ID: 20391774
[TBL] [Abstract][Full Text] [Related]
11. Analysis of IL4R haplotypes in predisposition to multiple sclerosis.
Mirel DB; Barcellos LF; Wang J; Hauser SL; Oksenberg JR; Erlich HA
Genes Immun; 2004 Mar; 5(2):138-41. PubMed ID: 14712310
[TBL] [Abstract][Full Text] [Related]
12. Risk conferring genes in multiple sclerosis.
Nischwitz S; Müller-Myhsok B; Weber F
FEBS Lett; 2011 Dec; 585(23):3789-97. PubMed ID: 21439284
[TBL] [Abstract][Full Text] [Related]
13. A humanized model for multiple sclerosis using HLA-DR2 and a human T-cell receptor.
Madsen LS; Andersson EC; Jansson L; krogsgaard M; Andersen CB; Engberg J; Strominger JL; Svejgaard A; Hjorth JP; Holmdahl R; Wucherpfennig KW; Fugger L
Nat Genet; 1999 Nov; 23(3):343-7. PubMed ID: 10610182
[TBL] [Abstract][Full Text] [Related]
14. Genetic association between polymorphisms in the BTG1 gene and multiple sclerosis.
Camiña-Tato M; Morcillo-Suárez C; Navarro A; Fernández M; Horga A; Montalban X; Comabella M
J Neuroimmunol; 2009 Aug; 213(1-2):142-7. PubMed ID: 19515430
[TBL] [Abstract][Full Text] [Related]
15. Single-nucleotide polymorphisms in HLA- and non-HLA genes associated with the development of antibodies to interferon-β therapy in multiple sclerosis patients.
Weber F; Cepok S; Wolf C; Berthele A; Uhr M; Bettecken T; Buck D; Hartung HP; Holsboer F; Müller-Myhsok B; Hemmer B
Pharmacogenomics J; 2012 Jun; 12(3):238-45. PubMed ID: 21502966
[TBL] [Abstract][Full Text] [Related]
16. [Enlightenment from genome-wide association study to genetics of psoriasis].
ZHANG XJ
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2009 Jul; 38(4):333-7. PubMed ID: 19693967
[TBL] [Abstract][Full Text] [Related]
17. Multiple sclerosis genetics 2010.
McElroy JP; Oksenberg JR
Neurol Clin; 2011 May; 29(2):219-31. PubMed ID: 21439438
[TBL] [Abstract][Full Text] [Related]
18. EVI5 is a risk gene for multiple sclerosis.
Hoppenbrouwers IA; Aulchenko YS; Ebers GC; Ramagopalan SV; Oostra BA; van Duijn CM; Hintzen RQ
Genes Immun; 2008 Jun; 9(4):334-7. PubMed ID: 18401352
[TBL] [Abstract][Full Text] [Related]
19. The tag SNP for HLA-DRB1*1501, rs3135388, is significantly associated with multiple sclerosis susceptibility: cost-effective high-throughput detection by real-time PCR.
Zivković M; Stanković A; Dincić E; Popović M; Popović S; Raicević R; Alavantić D
Clin Chim Acta; 2009 Aug; 406(1-2):27-30. PubMed ID: 19433080
[TBL] [Abstract][Full Text] [Related]
20. Fine mapping of multiple sclerosis susceptibility genes provides evidence of allelic heterogeneity at the IL2RA locus.
Perera D; Stankovich J; Butzkueven H; Taylor BV; Foote SJ; Kilpatrick TJ; Rubio JP
J Neuroimmunol; 2009 Jun; 211(1-2):105-9. PubMed ID: 19375175
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
